Frédéric Triebel
Chief Tech/Sci/R&D Officer bij IMMUTEP LIMITED
Vermogen: 2 M $ op 29-02-2024
Profiel
Founder of Immutep SAS, Frédéric Triebel currently is Executive Director & Chief Scientific Officer at Immutep Ltd.
and Co-Chief Executive Officer at Immutep SAS (a subsidiary of Immutep Ltd.).
In the past Dr. Triebel occupied the position of Principal at IGREC SASU and Professor at Université de Paris IV Paris-Sorbonne.
He received a doctorate from Université Paris 1 Panthéon-Sorbonne.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
IMMUTEP LTD
0.73% | 22-08-2023 | 8 653 764 ( 0.73% ) | 2 M $ | 29-02-2024 |
Actieve functies van Frédéric Triebel
Bedrijven | Functie | Begin |
---|---|---|
IMMUTEP LIMITED | Chief Tech/Sci/R&D Officer | 12-12-2014 |
Immutep SAS
Immutep SAS Pharmaceuticals: MajorHealth Technology Immutep SAS specializes in biotechnology research and development. It develops immunotherapy treatments for cancer and autoimmune diseases. The company was founded by Frédéric Triebel on October 17, 2001 and is headquartered Orsay, France. | Chief Executive Officer | 14-07-2016 |
Eerdere bekende functies van Frédéric Triebel
Bedrijven | Functie | Einde |
---|---|---|
Institut National de la Santé & de la Recherche Médicale
Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France. | Director/Board Member | 01-01-1996 |
Université de Paris IV Paris-Sorbonne | Corporate Officer/Principal | - |
IGREC SASU
IGREC SASU Miscellaneous Commercial ServicesCommercial Services IGREC SASU provides accounting services. It offers concepts of recovery before maturity, detection, classification and handling of disputes, and the concepts of sustainable improvement of payment delays and customer satisfaction. The company was founded in 1993 and is headquartered in Caraman, France. | Corporate Officer/Principal | - |
Opleiding van Frédéric Triebel
Université Paris 1 Panthéon-Sorbonne | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
IMMUTEP LIMITED | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
Institut National de la Santé & de la Recherche Médicale
Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France. | Commercial Services |
Université de Paris IV Paris-Sorbonne | Consumer Services |
IGREC SASU
IGREC SASU Miscellaneous Commercial ServicesCommercial Services IGREC SASU provides accounting services. It offers concepts of recovery before maturity, detection, classification and handling of disputes, and the concepts of sustainable improvement of payment delays and customer satisfaction. The company was founded in 1993 and is headquartered in Caraman, France. | Commercial Services |
Immutep SAS
Immutep SAS Pharmaceuticals: MajorHealth Technology Immutep SAS specializes in biotechnology research and development. It develops immunotherapy treatments for cancer and autoimmune diseases. The company was founded by Frédéric Triebel on October 17, 2001 and is headquartered Orsay, France. | Health Technology |